FLORIDA!A MEDICAID' Better Health Care for all Floridians. May

CHARLIE CRIST GOVERNOR FLORIDA!A MEDICAID' Better Health Care for all Floridians HOllY BENSON SECRETARY May 26. 2009 Policy Transmittal: HMO 09-01 Policy Transmittal: PS 09-01 RE: Year Thrcc PerFormance Measures Dear Medicaid Health Plan: This policy transmittal serves as notice that the Agency For Health Care Administration (Agency) has revised the Year Three PerFormance Measures to be submitted in accordance with the specifications in this transmittal and its related attachments. Section VIII. Quality Management, A.3.c. (limos and Reform and non-reform Fee-For-Service PSNs) and A.3.b. (non-reform Capitated PSNs) permit the Agency to modify performance measure reporting requirements with sixty (60) days advance notice. Altachment I, ivledicaid HMO and P N Specifications/or Pelformance Measures, is a list ofthe performance measures due to the Agency each year. You will no longer need to refercnce the previous years' policy transmittals to locate the most recent list of performance mea ure. The Ageney has provided notations if measures are new or have been revised From previou years and has included a column indicating the year of the HEDIS ational Means and Pereentiles that will be used as the performance benchmark For each measure. Altachment 2. ivledicaid HMO and PSN Pelforll1ance Measures. Version 2009, i a consolidated document listing all specifications For Agency-Defined Measures. Because Year Three is the final year of the Agency's phase-in schedule for performance measures, this list is a consolidated list with all measures that must be reported annually. Attachment 2 also includes an EXCEL chart exhibit (Exhibit A) that provides ICD-9-CM codes and medication information. This chart will be helpful to you regarding the performance measure specifications related to IIiV and/or AIDS. This policy transmittal serves to notice both Reform and on-reform health plans of the required perf0n11ance measures. In the event that a performance measure is not applicable because it measures a Reform-only benefit or because the health plan does not cover the service. the health plan should indicate "NB" when reporting that measure. 2727 Mahan Drive, MS# a Tallahassee, Florida 32308 Visit AHCA online at http://ahca.myflorida.com

Policy Transmittal: HMO 09-01 Policy Transmittal: PSN 09-01 May 26, 2009 Page Two If you havc any questions or require furthcr clarification, please do not hesitate to contact Deborah Mc amara of my staff at I11cnamard(aahca.myllorida.com or (850) 414-7528. CDS/dm Enclosurcs inccrely, ~~ Carlton D. S~ Dcputy Secretary for Medicaid

Attachment 1 Medicaid HMO and PSN Performance Measures Version 2009 HEDIS Note Benchmark Year 1 Adolescent Well Care Visits (AWC) 2 Adults Access to Preventive /Ambulatory Health Services (AAP) 3 Ambulatory Care (AMB) 4 Annual Dental Visits (ADV) 5 Antidepressant Medication Management (AMM) 6 BMI Assessment (ABA) 7 Breast Cancer Screening (BCS) 8 Cervical Cancer Screening (CCS) 9 Childhood Immunization Status (CIS) 10 Comprehensive Diabetes Care (CDC) Without Blood Pressure Measure 11 Controlling High Blood Pressure (CBP) 12 Follow-up Care for Children Prescribed ADHD Medication (ADD) 13 Frequency of Ongoing Prenatal Care (FPC) 14 Lead Screening in Children (LSC) 15 Mental Health Utilization Inpatient, Intermediate, & Ambulatory Services (MPT) 16 Persistence of Beta-Blocker Treatment after a Heart Attack (PBH) 17 Prenatal and Postpartum Care (PPC) 18 Use of Appropriate Medications for People With Asthma (ASM) 19 Well-Child Visits in the First 15 Months of Life (W15) 20 Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life (W34) Agency-Defined Measures HEDIS 2007 HEDIS 2008 N/A HEDIS 2007 HEDIS 2008 new HEDIS 2009 HEDIS 2008 HEDIS 2007 HEDIS 2008 HEDIS 2007 HEDIS 2007 HEDIS 2009 HEDIS 2008 HEDIS 2008 N/A HEDIS 2009 HEDIS 2007 HEDIS 2008 HEDIS 2007 HEDIS 2007 21 Follow-Up after Hospitalization for Mental Illness (FHM) updated 2010 22 23 Mental Health Readmission Rate (RER) Lipid Profile Annually (LPA) 2009 updated 2010 4/21/09

24 25 26 27 28 29 Attachment 1 Medicaid HMO and PSN Performance Measures Version 2009 Use of Angiotensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Receptor Blockers (ARB) Therapy (ACE) Use of Beta Agonist (UBA) Frequency of HIV Disease Monitoring Lab Tests (CD4 and VL) Highly Active Anti-Retroviral Treatment (HAART) HIV-Related Medical Visits (HIVV) Percentage of Enrollees Participating in Disease Management Program (DM) 2009 updated 2008 updated 2010 new 2010 new 2010 new N/A Prior Year Deleted Measures - Body Weight Monitoring and / Loss (includes BMI) deleted - Medication Regimen Adherence deleted - Foot Exam Annually deleted - Blood Glucose Self-Monitoring deleted - Asthma Action Plan deleted - CD4 Test Performed and Results deleted - Viral Load Test Performed and Results deleted - Smoking Cessation deleted 4/21/09

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Follow-up after Hospitalization for a Mental Illness (FHM) Description: The percent of enrollees who were hospitalized for a mental health diagnosis and were discharged to the community from an acute care facility and were seen on an outpatient basis by a mental health practitioner within seven days and within 30 days. Age/Gender: 6 years and older as of the date of discharge. Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled for 30 days following discharge. Exclusions: Enrollees who died, enrollees who were re-admitted within 7 days of discharge, or enrollees whose discharges were followed by readmission or direct transfer to a Statewide Inpatient Psychiatric Program (SIPP), a readmission or direct transfer to a Department of Juvenile Justice or Child Welfare Behavioral Health Overlay Service facility, members who receive Florida Assertive Community Treatment services, and members who are admitted to hospice, nursing facilities, state mental health facilities, and correctional institutions within the 7 days after discharge. Administrative Specification Numerator One: 7 Days: FHM-7 Denominator: Enrollees who were discharged to the community from an acute care facility (inpatient or crisis stabilization unit) who had a discharge diagnosis of ICD-9-CM codes 290.0 through 290.43, 293.0 through 298.9, 300.00 through 301.9, 302.7, 306.51 through 312.4 and 312.81 through 314.9, 315.3, 315.31, 315.5, 315.8, and 315.9 who were continuously enrolled for 7 days following discharge. Numerator: An outpatient follow-up encounter with a mental health practitioner (see definition below) up to seven days after hospital discharge. Numerator Two: 30 Days: FHM-30 Denominator: Enrollees who were discharged to the community from an acute care facility (inpatient or crisis stabilization unit) who had a discharge diagnosis of ICD-9-CM codes 290.0 through 290.43, 293.0 through 298.9, 300.00 through 301.9, 302.7, 306.51 through 312.4 and 312.81 through 314.9, 315.3, 315.31, 315.5, 315.8, and 315.9 who were continuously enrolled for 30 days following discharge. Numerator: An outpatient follow-up encounter with a mental health practitioner (see definition below) up to thirty days after hospital discharge. Page 1 of 11 04/14/2009

Allowable Encounter/Claim Codes Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures UB Revenue CPT HCPCS 0513, 0910, 0912, 0914, 0915 90772, 90801, 90802, 90804-90814, 90847, 90849, 90853, 90855, 90862, 99201, 99202, 99204, 99205, 99211-99215, 99241-99245 G0154 HE*, H0031 HO, H0031 TS, H0035, H0046, H2000 HO, H2000 HP, H2010 HE, H2010 HO, H2010 HQ, H2012, H2017, H2019 HK, H2019 HQ, H2019 HR, H2019 HM, H2019 HN, H2019 HO, S9127, T1001*, T1015, T1015 HE, T1023 HE *Must be provided by an RN who meets the definition of a mental health practitioner Mental Health Practitioner: A Florida licensed MD or doctor of osteopathy (DO) who is certified as a psychiatrist or child psychiatrist by the American Medical Specialties Board of Psychiatry and Neurology or by the American Osteopathic Board of Neurology and Psychiatry; or, if not certified, who successfully completed an accredited program of graduate medical or osteopathic education in psychiatry or child psychiatry. A Florida Licensed Psychologist or a doctoral level psychologist practicing under the auspices of a community mental health center and being supervised by a licensed psychologist. An individual who is certified in clinical social work by the American Board of Examiners; who is listed on the National Association of Social Worker s Clinical Register; or who is a Florida Licensed Clinical Social Worker; or who is a masters level social worker practicing under the auspices of a community mental health center and being supervised by a licensed clinical social worker. A Florida-licensed registered nurse (RN) who is certified by the American Nurses Credentialing Center (a subsidiary of the American Nurses Association) as a psychiatric nurse or mental health clinical nurse specialist, or who has a master s degree in nursing with a specialization in psychiatric/ mental health and two years of supervised clinical experience. A Florida-licensed Marriage and Family Therapist or a masters level marriage and family therapist practicing under the auspices of a community mental health center and being supervised by a Licensed Marriage and Family Therapist. A Florida Licensed Mental Health Counselor or a masters level counselor practicing under the auspices of a community mental health center and being supervised by a Licensed Mental Health Counselor. Page 2 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Mental Health Readmission Rate (RER) Description: The percent of enrollees who were hospitalized for a mental health diagnosis and were discharged to the community from an acute care facility and were readmitted for a mental health diagnosis within 30 days. Age/Gender: 6 years and older as of the date of discharge. Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled for 30 days following discharge. Exclusions: Enrollees who died, or enrollees whose discharges were followed by readmission or direct transfer to a Statewide Inpatient Psychiatric Program (SIPP), a readmission or direct transfer to a Department of Juvenile Justice or Child Welfare Behavioral Health Overlay Service facility, members who receive Florida Assertive Community Treatment Services, and members who are admitted to nursing facilities, state mental health treatment facilities, correctional institutions and hospice programs within the 30 days after discharge. Administrative Specification Denominator: Enrollees who were discharged to the community from an acute care facility (inpatient or crisis stabilization unit) who had a discharge diagnosis of ICD-9-CM codes 290.0 through 290.43, 293.0 through 298.9, 300.0 through 301.9, 302.7, 306.51 through 312.4 and 312.81 through 314.9, 315.3, 315.31, 315.5, 315.8, and 315.9 who were continuously enrolled for 30 days following discharge. Numerator: Readmission to an acute care facility (inpatient or crisis stabilization unit) with a diagnosis of ICD-9-CM codes 290.0 through 290.43, 293.0 through 298.9, 300.0 through 301.9, 302.7, 306.51 through 312.4 and 312.81 through 314.9, 315.3, 315.31, 315.5, 315.8, and 315.9 within 30 days following discharge. Lipid Profile Annually (LPA) Description: The percentage of members 18 to 85 years of age who had a diagnosis of hypertension and who had a lipid profile during the measurement year that includes total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides. Ages: 18 to 85 years of age as of December 31 of the measurement year. Data Collection Method: Administrative or Hybrid. Page 3 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Continuous Enrollment: In health plan for the measurement year with no more than a one month gap in coverage. Administrative Specification Denominator: Enrollees with hypertension as defined by the inclusion criteria for the HEDIS measure, Controlling High Blood Pressure, most recent edition. -OR- Numerator: Those beneficiaries in the denominator who have had a lipid profile in the measurement year that includes total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides. CPT Codes LOINC Codes Lipid Profile 80061 12912-2, 24331-1, 2569-2, 2570-0 Cholesterol, Total 82465 2093-3, 14646-4, 14647-2, 22748-8 HDL Cholesterol 83718 2085-9, 18263-4 Triglycerides 84478 1644-4, 2571-8, 3043-7, 3048-6, 14927-8, 30524-3 Hybrid Specification Denominator: A systematic sample drawn from the eligible population following the HEDIS Guidelines for Calculations and Sampling with a sample size of 411. Numerator: Refer to the Administrative Specification above. At a minimum, documentation in the medical record must include a note indicating the date on which the lipid profile (or its component parts) was performed. Use of Angiotensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Receptor Blockers (ARB) Therapy (ACE) Description: The percentage of members 18 years and older during the measurement year who were diagnosed with congestive heart failure, and who have at least one prescription filled for angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) during the measurement year. Page 4 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Eligible Population: Enrollees with a congestive heart failure diagnosis as determined by the method below. Diagnosis: Identify members as having heart failure (HF) who met at least one of the following criteria, during the measurement year: At least one outpatient visit with any HF diagnosis (Table HFM-A), Or At least one acute inpatient visit with any HF diagnosis (Table HFM-B) Table HFM-A: Codes to Identify Outpatient Visit for Heart Failure ICD-9-CM Diagnosis CPT UB Revenue 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9 WITH 99201-99205, 99211-99215, 99217-99220, 99241-99245, 99341-99345, 99347-99350, 99382-99386, 99392-99396, 99401-99404, 99411, 99412, 99420, 99429 051x, 0520-0523, 0526-0529, 057x- 059x, 077x, 0982, 0983 OR CPT Category II LVEF <40% 3021F Table HFM-B: Codes to Identify Inpatient Visit for Heart Failure ICD-9-CM Diagnosis CPT UB Revenue 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9 WITH 99221-99223, 99231-99233, 99238, 99239, 99251-99255, 99261-99263, 99291 Ages: 18 years and older as of December 31 of the measurement year. Data Collection Method: Administrative Data. No sampling allowed. 010x, 0110-0114, 0119, 0120-0124, 0129, 0130-0134, 0139, 0140-0144, 0149, 0150-0154, 0159, 016x, 020x- 022x, 072x, 0987 Continuous enrollment: In health plan for six months or more during the measurement year with a gap of no more than one month. Administrative Specification Denominator: The eligible population. Page 5 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Numerator: All members in the denominator population with at least one prescription filled during the measurement year for a medication from the therapeutic classes specified above. ACE inhibitors are defined with therapeutic class codes A4D and A4K. ARBs are defined with therapeutic class code A4F. Use of Beta Agonist (UBA) Description: The percentage of members 5 to 56 years of age during the measurement year who were identified as having persistent asthma and who had prescriptions for beta agonist medications filled during the measurement year. Eligible Population: Enrollees with asthma as defined by the inclusion criteria for the HEDIS measure, Use of Appropriate Medications for People with Asthma, most recent edition. Ages: 15 to 56 years as of December 31 of the measurement Year. Results should be stratified into three age groups and an overall total rate: 5 to 9 years old 10 to 17 years old 18 56 years old Total (Calculate total as the sum of the numerators for each age group divided by sum of the denominators for each age group). Data Collection Method: Administrative data. No sampling allowed. Continuous Enrollment: In health plan for six months or more during the measurement year with no more than a one month gap in coverage. Administrative Specification Denominator: The eligible population. Numerator: All members in the denominator with at least one prescription for beta agonist medications filled during the measurement year. Beta agonist medications are defined with the following therapeutic class code J5D and J5G. Frequency of HIV Disease Monitoring Lab Tests (CD4) and (VL) Description: The frequency of HIV disease monitoring lab tests performed in a calendar year. Eligible Population: Enrollees with HIV/AIDS as identified by ICD-9-CM diagnosis code 042, 079.53, or V08. Page 6 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Ages: No age limitations. Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled in the health plan a minimum of 9 months throughout the measurement year with gaps in enrollment permitted. Administrative Specification Frequency of CD4 T-cell Tests performed (CD4): Denominator: Total number of enrollees with HIV/AIDS in the health plan. Numerator: Three separate numerators are calculated: a. Enrollees with >= 3 tests performed in a 12 month period. b. Enrollees with 2 tests performed in 12 month period. c. Enrollees with 1 test performed in 12 month period. Frequency of Viral Load tests performed (VL) Denominator: Total number of enrollees with HIV/AIDS in health plan. Numerator: Three separate numerators are calculated: a. Enrollees with >= 3 tests performed in a 12 month period. b. Enrollees with 2 tests performed in 12 month period. c. Enrollees with 1 test performed in 12 month period. Highly Active Anti-Retroviral Treatment (HAART) Description: The percentage of enrollees with an AIDS diagnosis that have been prescribed a Highly Active Anti-Retroviral Treatment drug. Eligible Population: Enrollees with AIDS as identified by ICD-9-CM diagnosis code 042. Ages: No age limitations. Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled in the health plan a minimum of 9 months through-out the measurement year with gaps in enrollment permitted. Administrative Specification Page 7 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Denominator: Number of enrollees in the plan diagnosed with AIDS. Numerator: Number of enrollees who were prescribed a HAART regimen (see HIV/AIDS Attachment) within the measurement year. HIV-Related Medical Visits (HIVV) Description: The percentage of enrollees with HIV/AIDS who were seen by a physician, Physicians Assistant or Advanced Registered Nurse Practitioner for an HIV related medical visit (see HIV/AIDS Attachment) within the measurement year. Eligible Population: Enrollees with HIV/AIDS as identified by ICD-9-CM diagnosis code 042, 079.53, or V08. Ages: No age limitations. Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled in the health plan a minimum of 9 months through-out the measurement year with gaps in enrollment permitted. Administrative Specification Denominator: Number of enrollees with HIV/AIDS in the plan. Numerator: Three separate numerators are calculated: a. Enrollees who were seen twice in measurement year, <= 6 months apart. b. Enrollees who were seen more than twice in measurement year. c. Enrollees who were seen once in the measurement year. Percentage of Enrollees Participating in Disease Management Programs (DM) Description: The percentage of health plan enrollees with a specified disease state who are enrolled in the plan s disease management program. Eligible Population: All enrollees with the following diagnoses: 1. HIV/AIDS 2. Congestive Heart Failure 3. Diabetes Page 8 of 11 04/14/2009

4. Hypertension 5. Asthma Ages: No age limitations. Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures Data Collection Method: Administrative Data. No sampling allowed. Continuous Enrollment: Continuously enrolled for at least four months of the measurement year with no more than one month gap in coverage. Exclusions: Enrollees with multiple disease states may be counted in the denominator for one disease state only. The enrollee should be categorized by their highest disease state, as listed in hierarchical order above. Administrative Specification Numerator One: HIV/AIDS (HIV) Denominator: Enrollees with HIV/AIDS as identified by ICD-9-CM diagnosis code 042 or V08. Numerator: Those enrollees in the denominator who were enrolled in the disease management program for HIV/AIDS at least two months during the measurement year. Numerator Two: Congestive Heart Failure (CHF) Denominator: Members are identified for the eligible population through diagnosis criteria. Diagnosis: Identify members as having heart failure (HF) who met at least one of the following criteria, during the measurement year. At least one outpatient visit with any HF diagnosis (Table HFM-A), Or At least one acute inpatient visit with any HF diagnosis (Table HFM-B) Table HFM-A: Codes to Identify Outpatient Visit for Heart Failure ICD-9-CM Diagnosis CPT UB Revenue 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9 OR WITH 99201-99205, 99211-99215, 99217-99220, 99241-99245, 99341-99345, 99347-99350, 99382-99386, 99392-99396, 99401-99404, 99411, 99412, 99420, 99429 051x, 0520-0523, 0526-0529, 057x- 059x, 077x, 0982, 0983 Page 9 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures CPT Category II LVEF <40% 3021F Table HFM-B: Codes to Identify Inpatient Visit for Heart Failure ICD-9-CM Diagnosis CPT UB Revenue 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9 WITH 99221-99223, 99231-99233, 99238, 99239, 99251-99255, 99261-99263, 99291 010x, 0110-0114, 0119, 0120-0124, 0129, 0130-0134, 0139, 0140-0144, 0149, 0150-0154, 0159, 016x, 020x- 022x, 072x, 0987 Numerator: Those enrollees in the denominator who were enrolled in the disease management program for congestive heart failure two or more months during the measurement year. Numerator Three: Diabetes (DIA) Denominator: Enrollees with diabetes as defined by the inclusion criteria for the HEDIS measure, Comprehensive Diabetes Care, most recent edition. Numerator: Those enrollees in the denominator who were enrolled in the disease management program for diabetes at least two months during the measurement year. Numerator Four: Hypertension (HTN) Denominator: Enrollees with hypertension as defined by the inclusion criteria for the HEDIS measure, Controlling High Blood Pressure, most recent edition. Numerator: Those enrollees in the denominator who were enrolled in the disease management program for hypertension at least two months during the measurement year. Numerator Five: Asthma (AST) Denominator: Enrollees with asthma as defined by the inclusion criteria for the HEDIS measure, Use of Appropriate Medications for People with Asthma, most recent edition. Numerator: Those enrollees in the denominator who were enrolled in the disease management program for asthma at least two months during the measurement year. Optional Reporting: Other Disease States Page 10 of 11 04/14/2009

Attachment 2 Medicaid HMO 09-01 and PSN 09-01 Specifications for Performance Measures If the health plan operates disease management programs for disease states other than those specified above, the health plan may report the percentage of enrolled enrollees as an optional numerator(s) using the specification format for the required disease states. The health plan must provide a notation labeling the disease state of the optional program. Page 11 of 11 04/14/2009

HAART NDC Drug Name Drug Generic Name HIC3 00003362212 REYATAZ 300 MG CAPSULE ATAZANAVIR SULFATE W5C 00003362312 REYATAZ 100 MG CAPSULE ATAZANAVIR SULFATE W5C 00003362412 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 00003363112 REYATAZ 200 MG CAPSULE ATAZANAVIR SULFATE W5C 00004024451 INVIRASE 500 MG TABLET SAQUINAVIR MESYLATE W5C 00004024515 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 00004024648 FORTOVASE 200 MG SOFTGEL CAP SAQUINAVIR W5C 00006057062 CRIXIVAN 100 MG CAPSULE INDINAVIR SULFATE W5C 00006057142 CRIXIVAN 200 MG CAPSULE INDINAVIR SULFATE W5C 00006057143 CRIXIVAN 200 MG CAPSULE INDINAVIR SULFATE W5C 00006057301 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057318 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057340 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057342 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057354 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057362 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 00006057465 CRIXIVAN 333 MG CAPSULE INDINAVIR SULFATE W5C 00074194063 NORVIR 80 MG/ML SOLUTION RITONAVIR W5C 00074663322 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 00074663330 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 00074949202 NORVIR 100 MG CAPSULE RITONAVIR W5C 00074949254 NORVIR 100 MG CAPSULE RITONAVIR W5C 00173067200 AGENERASE 150 MG CAPSULE AMPRENAVIR/VITAMIN E W5C 00173067900 AGENERASE 50 MG CAPSULE AMPRENAVIR/VITAMIN E W5C 00173068700 AGENERASE 15 MG/ML ORAL SOLN AMPRENAVIR/VITAMIN E/PROP W5C 00173072100 LEXIVA 700 MG TABLET FOSAMPRENAVIR CALCIUM W5C 00173072700 LEXIVA 50 MG/ML SUSPENSION FOSAMPRENAVIR CALCIUM W5C 16590006418 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 16590006430 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 16590006460 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 16590006490 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 35356006706 LEXIVA 700 MG TABLET FOSAMPRENAVIR CALCIUM W5C 35356006760 LEXIVA 700 MG TABLET FOSAMPRENAVIR CALCIUM W5C 35356006806 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 35356006860 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 35356011406 REYATAZ 300 MG CAPSULE ATAZANAVIR SULFATE W5C 35356011430 REYATAZ 300 MG CAPSULE ATAZANAVIR SULFATE W5C 35356011701 VIRACEPT 625 MG TABLET NELFINAVIR MESYLATE W5C 35356013830 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 35356013918 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 35356013960 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 35356020760 REYATAZ 200 MG CAPSULE ATAZANAVIR SULFATE W5C 49999043103 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 52959028930 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 52959050712 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 52959050718 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 52959050724 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 52959050730 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 54569424200 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C Page 1

HAART 54569424201 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54569424202 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54569424203 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54569433500 NORVIR 100 MG CAPSULE RITONAVIR W5C 54569454300 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454301 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454302 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454303 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454304 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454305 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569454306 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54569456300 FORTOVASE 200 MG SOFTGEL CAP SAQUINAVIR W5C 54569456301 FORTOVASE 200 MG SOFTGEL CAP SAQUINAVIR W5C 54569461300 NORVIR 80 MG/ML SOLUTION RITONAVIR W5C 54569479200 NORVIR 100 MG CAPSULE RITONAVIR W5C 54569481300 AGENERASE 150 MG CAPSULE AMPRENAVIR/VITAMIN E W5C 54569553000 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 54569553200 REYATAZ 200 MG CAPSULE ATAZANAVIR SULFATE W5C 54569555000 LEXIVA 700 MG TABLET FOSAMPRENAVIR CALCIUM W5C 54569565600 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 54569566400 INVIRASE 500 MG TABLET SAQUINAVIR MESYLATE W5C 54569862000 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 54569862001 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 54868369900 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54868369901 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54868369902 INVIRASE 200 MG CAPSULE SAQUINAVIR MESYLATE W5C 54868378200 NORVIR 100 MG CAPSULE RITONAVIR W5C 54868378201 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 54868378202 NORVIR 100 MG CAPSULE RITONAVIR W5C 54868378203 NORVIR 100 MG SOFTGEL CAP RITONAVIR W5C 54868394700 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 54868411000 FORTOVASE 200 MG SOFTGEL CAP SAQUINAVIR W5C 54868411300 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 54868485400 REYATAZ 200 MG CAPSULE ATAZANAVIR SULFATE W5C 54868485700 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 54868495400 LEXIVA 700 MG TABLET FOSAMPRENAVIR CALCIUM W5C 54868506100 VIRACEPT 625 MG TABLET NELFINAVIR MESYLATE W5C 54868583800 REYATAZ 300 MG CAPSULE ATAZANAVIR SULFATE W5C 55175520807 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 55175520901 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 55289047727 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 55887023030 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 55887023060 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 55887023090 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 58016069900 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 58016069930 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 58016069960 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 58016069990 CRIXIVAN 400 MG CAPSULE INDINAVIR SULFATE W5C 60760001018 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 60760001063 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 63010001027 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 63010001030 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C Page 2

HAART 63010001190 VIRACEPT POWDER NELFINAVIR MESYLATE W5C 63010002770 VIRACEPT 625 MG TABLET NELFINAVIR MESYLATE W5C 68030728401 VIRACEPT 250 MG TABLET NELFINAVIR MESYLATE W5C 68258914201 REYATAZ 150 MG CAPSULE ATAZANAVIR SULFATE W5C 35356007306 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 35356007330 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 54569533400 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 54868466900 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 61958040101 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 68258900301 VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUM W5I 00003196401 ZERIT 15 MG CAPSULE STAVUDINE W5J 00003196501 ZERIT 20 MG CAPSULE STAVUDINE W5J 00003196601 ZERIT 30 MG CAPSULE STAVUDINE W5J 00003196701 ZERIT 40 MG CAPSULE STAVUDINE W5J 00003196801 ZERIT 1 MG/ML SOLUTION STAVUDINE W5J 00004022001 HIVID 0.375 MG TABLET ZALCITABINE W5J 00004022101 HIVID 0.750 MG TABLET ZALCITABINE W5J 00054005221 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 00081010793 RETROVIR IV INFUSION VIAL ZIDOVUDINE W5J 00081010855 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 00081010856 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 00081011318 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 00087661443 VIDEX 100 MG PACKET DIDANOSINE/SODIUM CITRATE W5J 00087661543 VIDEX 167 MG PACKET DIDANOSINE/SODIUM CITRATE W5J 00087661643 VIDEX 250 MG PACKET DIDANOSINE/SODIUM CITRATE W5J 00087663241 VIDEX 2 GM PEDIATRIC SOLN DIDANOSINE W5J 00087663341 VIDEX 4 GM PEDIATRIC SOLN DIDANOSINE W5J 00087665001 VIDEX 25 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 00087665101 VIDEX 50 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 00087665201 VIDEX 100 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 00087665301 VIDEX 150 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 00087666515 VIDEX 200 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 00087667117 VIDEX EC 125 MG CAP SA DIDANOSINE W5J 00087667217 VIDEX EC 200 MG CAP SA DIDANOSINE W5J 00087667317 VIDEX EC 250 MG CAP SA DIDANOSINE W5J 00087667417 VIDEX EC 400 MG CAP SA DIDANOSINE W5J 00093553006 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 00173010793 RETROVIR IV INFUSION VIAL ZIDOVUDINE W5J 00173010855 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 00173010856 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 00173011318 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 00173047001 EPIVIR 150 MG TABLET LAMIVUDINE W5J 00173047100 EPIVIR 10 MG/ML ORAL SOLN LAMIVUDINE W5J 00173050100 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 00173066100 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 00173066101 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 00173066400 ZIAGEN 20 MG/ML SOLUTION ABACAVIR SULFATE W5J 00173071400 EPIVIR 300 MG TABLET LAMIVUDINE W5J 00378504091 STAVUDINE 15 MG CAPSULE STAVUDINE W5J 00378504191 STAVUDINE 20 MG CAPSULE STAVUDINE W5J 00378504291 STAVUDINE 30 MG CAPSULE STAVUDINE W5J 00378504391 STAVUDINE 40 MG CAPSULE STAVUDINE W5J Page 3

HAART 00555058801 DIDANOSINE 200 MG DR CAPSULE DIDANOSINE W5J 00555058901 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 00555059001 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 31722050960 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 31722051560 STAVUDINE 15 MG CAPSULE STAVUDINE W5J 31722051660 STAVUDINE 20 MG CAPSULE STAVUDINE W5J 31722051760 STAVUDINE 30 MG CAPSULE STAVUDINE W5J 31722051860 STAVUDINE 40 MG CAPSULE STAVUDINE W5J 35356006530 EPIVIR 300 MG TABLET LAMIVUDINE W5J 35356006624 EPIVIR 10 MG/ML ORAL SOLN LAMIVUDINE W5J 35356007460 ZERIT 40 MG CAPSULE STAVUDINE W5J 35356007506 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 35356007560 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 35356018630 VIDEX EC 400 MG CAP SA DIDANOSINE W5J 35356020530 EMTRIVA 200 MG CAPSULE EMTRICITABINE W5J 35356025930 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 35356028560 ZERIT 30 MG CAPSULE STAVUDINE W5J 49999011906 EPIVIR 150 MG TABLET LAMIVUDINE W5J 49999011960 EPIVIR 150 MG TABLET LAMIVUDINE W5J 49999038618 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 50962045010 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 50962045205 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 52959038706 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 52959050802 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050804 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050806 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050808 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050814 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050815 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050860 EPIVIR 150 MG TABLET LAMIVUDINE W5J 52959050906 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050912 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050918 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050920 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050924 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050928 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 52959050930 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177200 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177201 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177202 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177203 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177204 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569177205 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54569365700 VIDEX 100 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 54569387700 HIVID 0.750 MG TABLET ZALCITABINE W5J 54569387701 HIVID 0.750 MG TABLET ZALCITABINE W5J 54569405300 ZERIT 30 MG CAPSULE STAVUDINE W5J 54569405400 ZERIT 40 MG CAPSULE STAVUDINE W5J 54569405401 ZERIT 40 MG CAPSULE STAVUDINE W5J 54569422100 EPIVIR 150 MG TABLET LAMIVUDINE W5J 54569422101 EPIVIR 150 MG TABLET LAMIVUDINE W5J 54569422102 EPIVIR 150 MG TABLET LAMIVUDINE W5J Page 4

HAART 54569431300 VIDEX 100 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 54569431301 VIDEX 100 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 54569433300 EPIVIR 10 MG/ML ORAL SOLN LAMIVUDINE W5J 54569433400 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 54569448500 HIVID 0.375 MG TABLET ZALCITABINE W5J 54569451400 VIDEX 4 GM PEDIATRIC SOLN DIDANOSINE W5J 54569453800 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 54569488300 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 54569490500 VIDEX 200 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 54569517600 VIDEX EC 400 MG CAP SA DIDANOSINE W5J 54569538700 ZERIT 1 MG/ML SOLUTION STAVUDINE W5J 54569539000 ZIAGEN 20 MG/ML SOLUTION ABACAVIR SULFATE W5J 54569541200 ZERIT 15 MG CAPSULE STAVUDINE W5J 54569548000 ZERIT 20 MG CAPSULE STAVUDINE W5J 54569550100 EPIVIR 300 MG TABLET LAMIVUDINE W5J 54569550400 VIDEX EC 250 MG CAP SA DIDANOSINE W5J 54569552100 EMTRIVA 200 MG CAPSULE EMTRICITABINE W5J 54569564200 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 54569564300 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 54868197400 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54868197402 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54868197403 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 54868249901 HIVID 0.375 MG TABLET ZALCITABINE W5J 54868250001 HIVID 0.750 MG TABLET ZALCITABINE W5J 54868250002 HIVID 0.750 MG TABLET ZALCITABINE W5J 54868250200 VIDEX 100 MG TABLET CHEWABLE DIDANOSINE/CALCIUM CARB/M W5J 54868250401 RETROVIR 10 MG/ML SYRUP ZIDOVUDINE W5J 54868335200 ZERIT 40 MG CAPSULE STAVUDINE W5J 54868335201 ZERIT 40 MG CAPSULE STAVUDINE W5J 54868335300 ZERIT 20 MG CAPSULE STAVUDINE W5J 54868336000 ZERIT 15 MG CAPSULE STAVUDINE W5J 54868344800 ZERIT 30 MG CAPSULE STAVUDINE W5J 54868369300 EPIVIR 150 MG TABLET LAMIVUDINE W5J 54868369302 EPIVIR 150 MG TABLET LAMIVUDINE W5J 54868452200 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 54868452201 ZIAGEN 300 MG TABLET ABACAVIR SULFATE W5J 54868466600 VIDEX EC 400 MG CAP SA DIDANOSINE W5J 54868485300 EMTRIVA 200 MG CAPSULE EMTRICITABINE W5J 54868541600 EPIVIR 300 MG TABLET LAMIVUDINE W5J 54868546400 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 54868559500 VIDEX EC 250 MG CAP SA DIDANOSINE W5J 55045220701 HIVID 0.750 MG TABLET ZALCITABINE W5J 55045354901 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 55175449401 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58016068900 EPIVIR 150 MG TABLET LAMIVUDINE W5J 58016068930 EPIVIR 150 MG TABLET LAMIVUDINE W5J 58016068960 EPIVIR 150 MG TABLET LAMIVUDINE W5J 58016068990 EPIVIR 150 MG TABLET LAMIVUDINE W5J 58016069000 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58016069018 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58016069030 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58016069060 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J Page 5

HAART 58016069090 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58016079500 EPIVIR 300 MG TABLET LAMIVUDINE W5J 58016079530 EPIVIR 300 MG TABLET LAMIVUDINE W5J 58016079560 EPIVIR 300 MG TABLET LAMIVUDINE W5J 58016079590 EPIVIR 300 MG TABLET LAMIVUDINE W5J 58016086400 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 58016086430 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 58016086460 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 58016086490 RETROVIR 300 MG TABLET ZIDOVUDINE W5J 58864046230 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58864046260 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 58864046293 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 61958060101 EMTRIVA 200 MG CAPSULE EMTRICITABINE W5J 61958060201 EMTRIVA 10 MG/ML SOLUTION EMTRICITABINE W5J 62584004611 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 62584004621 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 62584004811 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 62584004821 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 63304092060 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 65862002460 ZIDOVUDINE 300 MG TABLET ZIDOVUDINE W5J 65862004824 ZIDOVUDINE 50 MG/5 ML SYRUP ZIDOVUDINE W5J 65862010701 ZIDOVUDINE 100 MG CAPSULE ZIDOVUDINE W5J 65862031030 DIDANOSINE 125 MG DR CAPSULE DIDANOSINE W5J 65862031130 DIDANOSINE 200 MG DR CAPSULE DIDANOSINE W5J 65862031230 DIDANOSINE 250 MG DR CAPSULE DIDANOSINE W5J 65862031330 DIDANOSINE 400 MG DR CAPSULE DIDANOSINE W5J 67253010910 ZIDOVUDINE 100 MG CAPSULE ZIDOVUDINE W5J 67253096124 ZIDOVUDINE 50 MG/5 ML SYRUP ZIDOVUDINE W5J 68030605901 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 68030606001 EPIVIR 150 MG TABLET LAMIVUDINE W5J 68030606401 EPIVIR 150 MG TABLET LAMIVUDINE W5J 68030606501 RETROVIR 100 MG CAPSULE ZIDOVUDINE W5J 68258910801 EPIVIR 150 MG TABLET LAMIVUDINE W5J 68258912601 ZERIT 20 MG CAPSULE STAVUDINE W5J 00009376103 RESCRIPTOR 100 MG TABLET DELAVIRDINE MESYLATE W5K 00009757601 RESCRIPTOR 200 MG TABLET DELAVIRDINE MESYLATE W5K 00054390558 VIRAMUNE 50 MG/5 ML SUSP NEVIRAPINE W5K 00054464721 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00054464725 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00054864725 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00056047030 SUSTIVA 50 MG CAPSULE EFAVIRENZ W5K 00056047330 SUSTIVA 100 MG CAPSULE EFAVIRENZ W5K 00056047492 SUSTIVA 200 MG CAPSULE EFAVIRENZ W5K 00056051030 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 00597004601 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00597004660 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00597004661 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 00597004724 VIRAMUNE 50 MG/5 ML SUSP NEVIRAPINE W5K 35356006990 SUSTIVA 200 MG CAPSULE EFAVIRENZ W5K 35356007106 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 35356007160 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 35356007224 VIRAMUNE 50 MG/5 ML SUSP NEVIRAPINE W5K Page 6

HAART 35356011506 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 35356011530 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 54569456100 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 54569456101 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 54569456200 RESCRIPTOR 100 MG TABLET DELAVIRDINE MESYLATE W5K 54569461100 SUSTIVA 200 MG CAPSULE EFAVIRENZ W5K 54569512200 RESCRIPTOR 200 MG TABLET DELAVIRDINE MESYLATE W5K 54569537400 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 54569560200 RESCRIPTOR 200 MG TABLET DELAVIRDINE MESYLATE W5K 54868384400 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 54868384401 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 54868452000 RESCRIPTOR 200 MG TABLET DELAVIRDINE MESYLATE W5K 54868466800 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 54868586400 INTELENCE 100 MG TABLET ETRAVIRINE W5K 55289039203 VIRAMUNE 200 MG TABLET NEVIRAPINE W5K 59676057001 INTELENCE 100 MG TABLET ETRAVIRINE W5K 63010002036 RESCRIPTOR 100 MG TABLET DELAVIRDINE MESYLATE W5K 63010002118 RESCRIPTOR 200 MG TABLET DELAVIRDINE MESYLATE W5K 68258902001 SUSTIVA 600 MG TABLET EFAVIRENZ W5K 68258902101 SUSTIVA 200 MG CAPSULE EFAVIRENZ W5K 00173059500 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 00173059502 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 00173069100 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 00173069120 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 00173074200 EPZICOM TABLET ABACAVIR SULFATE/LAMIVUD W5L 16590006106 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 23490708706 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 35356010906 EPZICOM TABLET ABACAVIR SULFATE/LAMIVUD W5L 35356010930 EPZICOM TABLET ABACAVIR SULFATE/LAMIVUD W5L 35356011606 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 35356011660 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 49999006206 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 49999006210 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 49999006260 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054602 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054603 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054604 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054606 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054608 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054610 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054614 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054615 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054620 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 52959054628 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54569452400 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54569452401 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54569452402 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54569452403 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54569519100 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 54569559400 EPZICOM TABLET ABACAVIR SULFATE/LAMIVUD W5L 54868411400 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 54868411406 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L Page 7

HAART 54868560000 EPZICOM TABLET ABACAVIR SULFATE/LAMIVUD W5L 55175520706 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55289038904 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55289038906 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55289038914 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55289038920 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55887023130 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55887023160 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 55887023190 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 58016069800 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 58016069830 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 58016069860 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 58016069890 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 60760059504 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 60760059514 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 62682104801 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 66267050906 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 68030728301 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 68115009006 COMBIVIR TABLET LAMIVUDINE/ZIDOVUDINE W5L 68258915801 TRIZIVIR TABLET ABACAVIR/LAMIVUDINE/ZIDOV W5L 00074052260 KALETRA 100-25 MG TABLET RITONAVIR/LOPINAVIR W5M 00074395646 KALETRA 400-100/5 ML ORAL SOLU RITONAVIR/LOPINAVIR W5M 00074395977 KALETRA 133.3-33.3 MG SOFTGEL RITONAVIR/LOPINAVIR W5M 00074679922 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 35356011160 KALETRA 100-25 MG TABLET RITONAVIR/LOPINAVIR W5M 35356011201 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 35356011230 KALETRA 50-200 MG TABLET RITONAVIR/LOPINAVIR W5M 52959096812 KALETRA 100-25 MG TABLET RITONAVIR/LOPINAVIR W5M 54569514200 KALETRA SOFTGEL RITONAVIR/LOPINAVIR W5M 54569552500 KALETRA ORAL SOLUTION RITONAVIR/LOPINAVIR W5M 54569575200 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 54868452400 KALETRA 133.3-33.3 MG SOFTGEL RITONAVIR/LOPINAVIR W5M 54868556600 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 55045348201 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 55289093118 KALETRA SOFTGEL RITONAVIR/LOPINAVIR W5M 55289094712 KALETRA 200-50 MG TABLET RITONAVIR/LOPINAVIR W5M 00004038039 FUZEON CONVENIENCE KIT ENFUVIRTIDE W5N 35356020660 FUZEON CONVENIENCE KIT ENFUVIRTIDE W5N 54569578100 FUZEON CONVENIENCE KIT ENFUVIRTIDE W5N 35356007006 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 35356007030 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 52959096903 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 54569558800 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 54868514100 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 55045348103 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 61958070101 TRUVADA TABLET EMTRICITABINE/TENOFOVIR W5O 00597000201 APTIVUS 100 MG/ML SOLUTION TIPRANAVIR/VITAMIN E TPGS W5P 00597000302 APTIVUS 250 MG CAPSULE TIPRANAVIR W5P 35356011301 PREZISTA 300 MG TABLET DARUNAVIR ETHANOLATE W5P 35356011330 PREZISTA 300 MG TABLET DARUNAVIR ETHANOLATE W5P 35356028460 PREZISTA 600 MG TABLET DARUNAVIR ETHANOLATE W5P 54569581400 PREZISTA 300 MG TABLET DARUNAVIR ETHANOLATE W5P Page 8

HAART 54868563100 PREZISTA 300 MG TABLET DARUNAVIR ETHANOLATE W5P 59676056001 PREZISTA 300 MG TABLET DARUNAVIR ETHANOLATE W5P 59676056101 PREZISTA 400 MG TABLET DARUNAVIR ETHANOLATE W5P 59676056201 PREZISTA 600 MG TABLET DARUNAVIR ETHANOLATE W5P 59676056301 PREZISTA 75 MG TABLET DARUNAVIR ETHANOLATE W5P 00069080760 SELZENTRY 150 MG TABLET MARAVIROC W5T 00069080860 SELZENTRY 300 MG TABLET MARAVIROC W5T 35356020860 SELZENTRY 150 MG TABLET MARAVIROC W5T 35356020960 SELZENTRY 300 MG TABLET MARAVIROC W5T 54868580900 SELZENTRY 300 MG TABLET MARAVIROC W5T 00006022761 ISENTRESS 400 MG TABLET RALTEGRAVIR POTASSIUM W5U 35356011006 ISENTRESS 400 MG TABLET RALTEGRAVIR POTASSIUM W5U 35356011060 ISENTRESS 400 MG TABLET RALTEGRAVIR POTASSIUM W5U 54569603400 ISENTRESS 400 MG TABLET RALTEGRAVIR POTASSIUM W5U 54868011700 ISENTRESS 400 MG TABLET RALTEGRAVIR POTASSIUM W5U Page 9